Key statistics
On Wednesday, Pyxis Oncology Inc (PYXS:NSQ) closed at 1.35, 62.03% above the 52 week low of 0.8332 set on Apr 07, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 1.36 |
|---|---|
| High | 1.37 |
| Low | 1.28 |
| Bid | 1.29 |
| Offer | 1.40 |
| Previous close | 1.39 |
| Average volume | 671.46k |
|---|---|
| Shares outstanding | 62.26m |
| Free float | 46.98m |
| P/E (TTM) | -- |
| Market cap | 86.55m USD |
| EPS (TTM) | -1.58 USD |
Data delayed at least 15 minutes, as of Feb 11 2026 21:00 GMT.
More ▼
Announcements
- Pyxis Oncology Announces Interim CEO Appointment and Leadership Transition to Support Strategic Focus and Program Continuity
- Pyxis Oncology Announces Positive Preliminary Phase 1 Data for Micvotabart Pelidotin (MICVO) in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
- Pyxis Oncology to Participate in Upcoming Investor Conferences
- Pyxis Oncology Provides Business Update and Reports Third Quarter 2025 Financial Results
- Pyxis Oncology to Present Translational Data and Key Biology Findings Elucidating the Mechanism of Action of MICVO at Upcoming Medical Meetings
- Pyxis Oncology Appoints Alex Kane as Senior Vice President, Investor Relations & Capital Markets
- Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Pyxis Oncology to Participate in September Investor and Industry Conferences
- Pyxis Oncology Reports Second Quarter 2025 Financial Results and Provides Business Update
- Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
More ▼
